Search results
Results from the WOW.Com Content Network
As of 2008, research in this area is active. [ 27 ] Another avenue for novel anti-cancer therapies is re-engineering some of the currently used conventional antibodies like trastuzumab (targeting HER2/neu ), cetuximab and panitumumab (both targeting the EGF receptor ), using the BiTE approach.
An anticoagulant, commonly known as a blood thinner, is a chemical substance that prevents or reduces the coagulation of blood, prolonging the clotting time. [1] Some occur naturally in blood-eating animals, such as leeches and mosquitoes, which help keep the bite area unclotted long enough for the animal to obtain blood.
President Laura Roslin visits Galactica doctor Sherman Cottle about her cancer. Cottle determines that Roslin's cancer is far beyond surgical means of removal and suggests an aggressive chemotherapy-like treatment. Due to her mother's experiences with the treatment, Roslin refuses and decides to instead go on chamalla, an alternative means of ...
The Institute moved in 2008 to a new research building built by Reiach and Hall Architects. [3] Professor John Wyke became Director in 1987, Professor Karen Vousden in 2002 and Professor Owen Sansom in 2017. [4] Research groups at the Beatson Institute study cancer initiation, metabolism and metastasis. The Institute holds an annual meeting ...
The tube contains bromadiolone, a second-generation (superwarfarin) anticoagulant. The label in Dutch states, in part: Contains an anticoagulant with prolonged activity. Antidote Vitamin K1. Vitamin K 2 (menaquinone). In menaquinone the side chain is composed of a varying number of isoprenoid residues.
Neutron capture therapy is a binary system that consists of two separate components to achieve its therapeutic effect. Each component in itself is non-tumoricidal, but when combined they can be highly lethal to cancer cells.
Identified in 1940, dicoumarol became the prototype of the 4-hydroxycoumarin anticoagulant drug class. Dicoumarol itself, for a short time, was employed as a medicinal anticoagulant drug, but since the mid-1950s has been replaced by its simpler derivative warfarin, and other 4-hydroxycoumarin drugs. It is given orally, and it acts within two days.
The clinical usefulness of ESR is limited to monitoring the response to therapy in certain inflammatory diseases such as temporal arteritis, polymyalgia rheumatica and rheumatoid arthritis. It can also be used as a crude measure of response in Hodgkin's lymphoma. Additionally, ESR levels are used to define one of the several possible adverse ...